Why it may matterVerify against the original reporting
The combination of an expected mid-single-digit revenue decline in Q3, a meaningful EBITDA pullback, and a stated risk of delisting from Nasdaq (potential move to OTC) can reduce liquidity, widen bid-ask spreads, and compress valuation for MAPS in the near term. Historically, Nasdaq delistings of smaller-cap names have triggered multiple compression in price and liquidity while OTC transition can take time to stabilize trading; the magnitude depends on OTC liquidity and investor perception of cannabis-sector risk.
AI summary
What happened, with direct paths to the underlying reporting
WM Technology reported Q2 2026 revenue of $42.4 million and net income of $2.9 million, with Adjusted EBITDA of $5.0 million, down year over year. The company guided Q3 revenue to fall by mid-single digits and flagged the potential delisting/deregistration from Nasdaq, which could pressure MAPS liquidity and trading unless OTC liquidity proves stable. Cash rose to $60.5 million, underpinning flexibility for selective investments.
Q2 2026 revenue $42.4M; net income $2.9M; MAPS ticker.
Average paying clients 5,040; ARPU $2,807; churn in established markets.
Adjusted EBITDA $5.0M; down from $11.7M prior year; cash $60.5M.
Q3 2026 revenue guided to decline mid-single digits sequentially.
Notes of potential Nasdaq delisting; possible move to OTC could affect liquidity.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Weedmaps co-founders propose taking the company private for $100 million. MAPS stock jumped 13.9% to $1.39 amid buyout offer. WM faces challenges from competition and declining ma…
